BG108435A - Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride - Google Patents
Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochlorideInfo
- Publication number
- BG108435A BG108435A BG108435A BG10843503A BG108435A BG 108435 A BG108435 A BG 108435A BG 108435 A BG108435 A BG 108435A BG 10843503 A BG10843503 A BG 10843503A BG 108435 A BG108435 A BG 108435A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alpha
- hydrochloride
- hydroxybutyl
- piperidinyl
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN484MA2001 | 2001-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
BG108435A true BG108435A (en) | 2004-12-30 |
Family
ID=34566868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG108435A BG108435A (en) | 2001-06-18 | 2003-12-11 | Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP1399422A2 (fr) |
JP (2) | JP2005507374A (fr) |
KR (1) | KR20040015734A (fr) |
CN (1) | CN100390145C (fr) |
AU (1) | AU2001278094B2 (fr) |
BG (1) | BG108435A (fr) |
BR (1) | BR0117054A (fr) |
CA (2) | CA2646802A1 (fr) |
CO (1) | CO5540340A2 (fr) |
CZ (1) | CZ20033358A3 (fr) |
EE (1) | EE200400010A (fr) |
HU (1) | HUP0401546A2 (fr) |
IL (2) | IL159266A0 (fr) |
MX (1) | MXPA03011728A (fr) |
NZ (1) | NZ530118A (fr) |
PL (1) | PL367632A1 (fr) |
RU (1) | RU2269516C2 (fr) |
SK (1) | SK15372003A3 (fr) |
WO (1) | WO2002102777A2 (fr) |
ZA (1) | ZA200309557B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020177608A1 (en) * | 2001-04-09 | 2002-11-28 | Ben-Zion Dolitzky | Polymorphs of fexofenadine hydrochloride |
DE03757471T1 (de) | 2002-06-10 | 2005-09-01 | Teva Pharmaceutical Industries Ltd. | Polymorphe form xvi von fexofenadin-hydrochlorid |
GB0319935D0 (en) * | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
CA2560882A1 (fr) * | 2004-04-26 | 2005-11-03 | Teva Pharmaceutical Industries Ltd. | Formes cristallines d'hydrochlorure de fexofenadine, et procedes pour les preparer |
ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
ITMI20041568A1 (it) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "polimorfi di fexofenadina base" |
JP2008514641A (ja) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶形フェキソフェナジン、およびその調製方法 |
WO2007007347A1 (fr) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Procédé industriel de préparation du chlorhydrate de fexofénadine avec un minimum de produits secondaires |
EP2105134A1 (fr) | 2008-03-24 | 2009-09-30 | Ranbaxy Laboratories Limited | Hydrochlorure de fexofenadine amorphe stable |
CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
CA2189007C (fr) | 1994-05-18 | 2004-03-02 | Daniel R. Henton | Methodes pour preparer des formes anhydres et hydratees de derives antihistaminiques de la piperidine; leurs formes polymorphes et pseudomorphes |
US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
IN191492B (fr) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
GB0018691D0 (en) * | 2000-07-28 | 2000-09-20 | Rolabo Sl | Process |
-
2001
- 2001-07-31 EE EEP200400010A patent/EE200400010A/xx unknown
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/ja active Pending
- 2001-07-31 EP EP01956057A patent/EP1399422A2/fr not_active Withdrawn
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/pt not_active Application Discontinuation
- 2001-07-31 CA CA002646802A patent/CA2646802A1/fr not_active Abandoned
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/ru not_active IP Right Cessation
- 2001-07-31 CN CNB018233791A patent/CN100390145C/zh not_active Expired - Fee Related
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/hu unknown
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/fr active IP Right Grant
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/sk unknown
- 2001-07-31 EP EP10010066A patent/EP2261209A1/fr not_active Withdrawn
- 2001-07-31 CA CA002450858A patent/CA2450858C/fr not_active Expired - Fee Related
- 2001-07-31 IL IL15926601A patent/IL159266A0/xx unknown
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 PL PL01367632A patent/PL367632A1/xx not_active Application Discontinuation
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/es active IP Right Grant
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/ko not_active Application Discontinuation
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/cs unknown
-
2003
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/xx unknown
- 2003-12-11 BG BG108435A patent/BG108435A/xx unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/es not_active Application Discontinuation
-
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2004101045A (ru) | 2005-06-27 |
CO5540340A2 (es) | 2005-07-29 |
CA2646802A1 (fr) | 2002-12-27 |
ZA200309557B (en) | 2004-09-14 |
MXPA03011728A (es) | 2004-07-08 |
RU2269516C2 (ru) | 2006-02-10 |
WO2002102777A8 (fr) | 2003-10-30 |
CA2450858C (fr) | 2009-04-07 |
BR0117054A (pt) | 2004-07-27 |
IL159266A (en) | 2010-11-30 |
PL367632A1 (en) | 2005-03-07 |
AU2001278094B2 (en) | 2006-01-12 |
EP2261209A1 (fr) | 2010-12-15 |
EE200400010A (et) | 2004-02-16 |
EP1399422A2 (fr) | 2004-03-24 |
JP2008094848A (ja) | 2008-04-24 |
HUP0401546A2 (hu) | 2004-12-28 |
SK15372003A3 (sk) | 2004-08-03 |
IL159266A0 (en) | 2004-06-01 |
CN1518540A (zh) | 2004-08-04 |
KR20040015734A (ko) | 2004-02-19 |
WO2002102777A3 (fr) | 2003-02-27 |
CZ20033358A3 (en) | 2004-04-14 |
CA2450858A1 (fr) | 2002-12-27 |
NZ530118A (en) | 2007-05-31 |
WO2002102777A2 (fr) | 2002-12-27 |
CN100390145C (zh) | 2008-05-28 |
JP2005507374A (ja) | 2005-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010006179A (es) | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico. | |
BG108435A (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride | |
DK153709B (da) | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanolderivater | |
WO2007127297A3 (fr) | Formes cristallines d'un composé de diméthylphényle | |
NO162819B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyrederivater. | |
NO319873B1 (no) | Fremgangsmate for fremstilling av antihistaminiske 4-difenylmetyl/difenylmetoksypiperidinderivater, nye mellomprodukter og anvendelse av disse | |
TW200734038A (en) | Novel dispersant and compositions thereof | |
JP2009533369A5 (fr) | ||
WO2007072087A3 (fr) | Nouveau procédé pour la production de chlorhydrate de donépézil polymorphe (i) extrêmement pur | |
NZ555095A (en) | Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines | |
AU2005272389A1 (en) | Novel cyclic aminobenzoic acid derivative | |
US5166148A (en) | 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity | |
WO2008032338A3 (fr) | Procédé amélioré de préparation d'ézétimibe et de ses intermédiaires | |
JP5673729B2 (ja) | 4−置換又は非置換テトラヒドロピラン−4−カルボン酸化合物又はそのエステル化合物の製法 | |
JP2010536713A5 (fr) | ||
CA2429563C (fr) | Methode de preparation de donepezil | |
NO20082474L (no) | Fremgangsmate for fremstilling av en leukotrienantagonist og intermediater derav | |
JP5585822B2 (ja) | 光学活性ニペコチン酸誘導体の製造方法 | |
TW200637856A (en) | Process for producing thiazolidinedion compound and intermediate thereof | |
PL353977A1 (en) | Method of obtaining 4-[1-hydroxy-4-[4-(hydroxydiphenyldimethyl)-1-piperidinylbutyl]-alpha,alpha-dimethylbenzene acetic acid | |
AU2008288430A1 (en) | Novel preparation process | |
NO20070776L (no) | Forbedret prosess for fremstilling av mirtazapin | |
WO2009047797A3 (fr) | Procédé de préparation d'un dérivé du perhydroisoindole | |
JP5796836B2 (ja) | ピタバスタチンまたはその塩の中間体の製造方法 | |
WO2009084030A3 (fr) | Procédé amélioré de préparation de la forme iii du chlorhydrate de la 1-benzyl-4-(5,6-diméthoxyindanon-2-yl)méthylpipéridine |